Cormorant Asset Management’s NEVRO CORP. NVRO Stock Holding History

Cormorant Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-100,000	Closed	-$9.09M	–	55
2017 Q3	$9.09M	Sell	100,000 -170,000	-63%	-$14.6M	1.6%	21
2017 Q2	$20.1M	Sell	270,000 -80,000	-23%	-$6.41M	3.33%	8
2017 Q1	$32.8M	Sell	350,000 -251,044	-42%	-$22.7M	4.76%	2
2016 Q4	$43.7M	Buy	601,044 +110,000	+22%	+$9.42M	5.89%	3
2016 Q3	$51.3M	Hold	491,044	–	–	5.65%	2
2016 Q2	$36.2M	Buy	491,044 +5,658	+1%	+$384K	5.14%	2
2016 Q1	$27.3M	Buy	485,386 +220,000	+83%	+$13M	4.11%	6
2015 Q4	$17.9M	Hold	265,386	–	–	2.14%	14
2015 Q3	$12.3M	Buy	265,386 +56,886	+27%	+$2.76M	1.97%	15
2015 Q2	$11.2M	Buy	208,500 +200,000	+2,353%	+$10.2M	1.49%	22
2015 Q1	$407K	Sell	8,500 -1,500	-15%	-$65.1K	0.06%	69
2014 Q4	$387K	Buy	+10,000	New	+$315K	0.06%	69

Other funds holding NVRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Cormorant Asset Management's NVRO Position: Q4 2017 in Review

Cormorant Asset Management sold out of NEVRO CORP. (NVRO) in Q4 2017, closing a stake of 100,000 shares — an estimated $9.09M sold.

Cormorant Asset Management first reported a position in NVRO in Q4 2014 and held it in 12 quarters. The position peaked at $51.3M in Q3 2016. 194 funds tracked by Wall St. Rank hold NVRO as of Q4 2017.

Cormorant Asset Management reported no remaining NEVRO CORP. position as of Q4 2017 after selling out during the quarter.
Cormorant Asset Management sold 100,000 NEVRO CORP. shares in Q4 2017, an estimated $9.09M.
Cormorant Asset Management first reported a position in NEVRO CORP. in Q4 2014 and held it in 12 quarters.
Cormorant Asset Management's NEVRO CORP. position peaked at $51.3M in Q3 2016.
194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2017.

Based on Cormorant Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.